Clinical Trials · NCT01508806
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 30
- Start date
- Aug 2005
- Locations
- 1 site, Australia
- Primary endpoint
- Area under the Curve (AUC)